Cargando…
Rituximab in treatment of anti-GBM antibody glomerulonephritis: A case report and literature review
RATIONALE: Anti-glomerular basement membrane (GBM) disease is a T cell-mediated disease that has a poor prognosis with conventional therapy. We tested rituximab as a primary therapy to reduce anti-GBM antibody produced by B cells. PATIENT CONCERNS: A 53-year old woman with complaints of a fever, hea...
Autores principales: | Uematsu-Uchida, Mayu, Ohira, Takehiro, Tomita, Shigeki, Satonaka, Hiroshi, Tojo, Akihiro, Ishimitsu, Toshihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946414/ https://www.ncbi.nlm.nih.gov/pubmed/31689860 http://dx.doi.org/10.1097/MD.0000000000017801 |
Ejemplares similares
-
Concurrent anti-neutrophil cytoplasmic antibody-associated glomerulonephritis and IgG4-associated tubulointerstitial nephritis with C3 glomerulonephritis: A case report
por: Feng, Jianan, et al.
Publicado: (2020) -
Pneumocystis pneumonia secondary to intensive immunosuppression treatment for anti-GBM disease complicated with IgA nephropathy: A case report and literature review
por: Zhang, Manyu, et al.
Publicado: (2021) -
C3 glomerulonephritis in multiple myeloma: A case report and literature review
por: Yin, Guang, et al.
Publicado: (2016) -
Spontaneous remission of membranous glomerulonephritis with successful fetal outcome: A case report and literature review
por: Huang, Yan-Mei, et al.
Publicado: (2016) -
A case of crescentic glomerulonephritis in a patient with COVID-19 infection: A case report and literature review
por: Alawad, Mouhammad J., et al.
Publicado: (2022)